These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6258812)

  • 41. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy).
    Trivello R; Ngatchu T; Marin V; Moretti G; Malatesta R; Maini P; Moschen ME; Baldo V; De Marzi L; Majori S; Puppo A; Renzulli G
    Ann Clin Lab Sci; 1996; 26(2):154-9. PubMed ID: 8852425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enterovirus circulation in wastewater and behavior of some serotypes during sewage treatment in Monastir, Tunisia.
    Belguith K; Hassen A; Bouslama L; Khira S; Aouni M
    J Environ Health; 2007 Jun; 69(10):52-6. PubMed ID: 17583297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Herd effect and virus eradication with use of killed poliovirus vaccine.
    Salk D
    Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poliovirus vaccine strains in sewage and river water in South Africa.
    Pavlov DN
    Can J Microbiol; 2006 Aug; 52(8):717-23. PubMed ID: 16917529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Distribution and characteristics of poliovirus strains circulating in Poland in 1968-1972. II. Genetic characteristics of strains isolated during the 1968 poliomyelitis epidemic, from sporadic cases and from sewage].
    Kańtoch M; Dobrowolska H; Jarzabek Z; Jankowski M
    Med Dosw Mikrobiol; 1975; 27(4):365-71. PubMed ID: 175225
    [No Abstract]   [Full Text] [Related]  

  • 50. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.
    Ivanov AP; Dragunsky EM; Chumakov KM
    J Infect Dis; 2006 Feb; 193(4):598-600. PubMed ID: 16425140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 53. Concentration and purification of poliovirus by immune adsorption on immobilized antibodies.
    van der Marel P; van Wezel AL; Hazendonk AG; Kooistra A
    Dev Biol Stand; 1980; 46():267-73. PubMed ID: 6245002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
    Rümke HC
    Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
    [No Abstract]   [Full Text] [Related]  

  • 55. Environmental surveillance of poliovirus in Italy: pilot study.
    Patti AM; Santi AL; Fiore L; Vellucci L; De Stefano D; Bellelli E; Barbuti S; Fara GM
    Ann Ig; 2003; 15(2):97-105. PubMed ID: 12838824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication.
    Martín J
    Biologicals; 2006 Jun; 34(2):117-22. PubMed ID: 16650772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Microbiological studies on waste water treatment by medical schools and hospitals. (I) Basic experimental studies on the treatment of cresol, phenol and formalin (author's transl)].
    Sayama N
    Nihon Eiseigaku Zasshi; 1980 Feb; 34(6):733-42. PubMed ID: 7392289
    [No Abstract]   [Full Text] [Related]  

  • 58. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?
    Dowdle WR; Wolff C; Sanders R; Lambert S; Best M
    Bull World Health Organ; 2004 Jan; 82(1):59-62. PubMed ID: 15106302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current advances in viral diagnostic technology applicable to polio vaccination and diagnosis.
    Chernesky MA
    Rev Infect Dis; 1984; 6 Suppl 2():S525-7. PubMed ID: 6330851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.